Work

UPASHAYA investigates the consequences of cfDNA fragmentation on the loss of genetic information in liquid biopsy-based cancer detection

Year: 2026
Type: article
Abstract: Clinical genomic profiling of circulating cell-free DNA (cfDNA) from liquid biopsies is routinely used for non-invasive cancer diagnosis and monitoring. However, differential fragmentation of blood cfDNA can lead to systematic loss of genetic information. It remains unclear whether such degradation compromises clinically relevant oncogenic regions across cancer types. To address this, we introduced UPASHAYA ( Uncovering Potential Areas of Shadowed Heterochromatin Associated Yielding Aberrations ) for investigating the consequence of cfDNA fragmentation across 317 samples spanning pan-cancer and non-cancer cohorts. We identified ‘penumbra regions’, open chromatin domains undergoing elevated nuclease-mediated degradation, creating clinical blind spots for druggable cancer genes. Structurally, these regions feature an abundance of small fragments (<150 bp) and a distinct fragment-end signature, including elevated C-end and C/G frequencies at the second motif position. This chromatin-driven degradation is independent of tumor shedding, showing consistent penumbra enrichment across low- and high-shedding cancers. Furthermore, gene-dense chromosomes, namely 17 and 19, emerged as major depletion hotspots. These penumbra regions are cancer-type-specific, impacting regulatory elements and actionable oncogenic hotspot exons, potentially hindering minimal residual disease detection. Our findings highlight a critical biological vulnerability and call for careful interpretation of clinical genomic data for precision medicine.
Language: English
Subfield: Cancer Research
Open Access status: gold
Estimated APC paid: $4,190
OpenAlex ID: W7203548024
FWCI:
Cites: 51
Cited by:
Related to: 10